RJA 12b

I plan on using some of the same sources as my background essay for the argumentative one; they were extremely informative and thorough, and provide much more than I could contain in the background essay.  As such, these are the same sources as listed in RJA 12a, but annotated. Works Cited Emery, Jon. "The challenge of integrating genetic medicine into primary care." BMJ 322.1027 (2001): n.pag. BMJ Journals. Web. 31 Jan. 2012. <http://www.bmj.com/content/322/7293/1027.short>. One of the discussions of my argumentative essay revolves around the challenges that doctors and medical practitioners face, and how difficult it might be to integrate something new that challenges how even the most minute of day-to-day tasks are done.  This article provides a wealth of information regarding genetic procedures that have already integrated, and some challenges that might be over the horizon. Juengst, Eric T. "Can Enhancement Be Distinguished from Prevention in Genetic Medicine?." Journal of Medicine and Philosophy 22.2 (1997): 125-142. Oxford Journals. Web. 31 Jan. 2012. <http://jmp.oxfordjournals.org/content/22/2/125.full.pdf+html>. A huge aspect of the ethical debate with genetic medicine revolves around whether it will be used to fix problems that were caused by choice versus those caused by disease.  This article goes into some of the challenges that go into this process, a big part of it being the ability to distinguish enhancement from prevention. US Department of Energy Genome Programs. "Medicine and the New Genetics." Human Genome Project Information. National Institutes of Health, 19 Sept. 2011. Web. 28 Feb. 2012. <http://genomics.energy.gov>. The Human Genome Project has been the kick-off point for much of this research, and no one has it better documented and explained than our very own government.  This resource is broad and encompasses various aspects of genetic medicine; the legal and ethical point, to the research that lies ahead, to the achievements and challenges faced by doctors and scientists.